Literature DB >> 7945793

Conformation of bilirubin oxidase in native and denatured states.

T Samejima1, C S Wu, K Shiboya, H Kaji, S Koikeda, K Ando, J T Yang.   

Abstract

The conformation of bilirubin oxidase (EC 1.3.3.5) from Myrothecium verrucaria was studied by circular dichroism (CD). The far-UV CD spectrum showed a single minimum at 215 nm and a maximum near 198 nm, suggesting the dominance of beta-sheets. There was another negative band at 187 nm that is absent from the spectra of model alpha-helix or beta-sheet. CD analysis by the method of Chang et al. agreed well with the estimates based on the Chou and Fasman sequence-predictive method, but the Provencher-Glöckner method of CD analysis agreed well with the sequence-predictive method of Garnier et al. At pH 12 the 215- and 187-nm bands completely disappeared and the protein was denatured. This denaturation was accompanied by the appearance of a large positive band at 250 nm, probably due to ionization of tyrosine residues. In 20 mM sodium dodecyl sulfate the magnitude of the 215-nm band increased, but the spectrum transformed to that of partial helices after heating at 100 degrees C. In 6 M guanidine hydrochloride the far-UV CD spectrum was monotonic and became more negative at the lower wavelength limit (near 212 nm), suggesting that the secondary structure of the protein was disrupted. However, the near-UV CD spectrum retained residual aromatic bands even after heating at 100 degrees C. Thus, our denaturation studies suggest that bilirubin oxidase has a rigid tertiary structure.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945793     DOI: 10.1007/bf01901563

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  26 in total

1.  Enzymatic removal of bilirubin toxicity by bilirubin oxidase in vitro and excretion of degradation products in vivo.

Authors:  M Kimura; Y Matsumura; T Konno; Y Miyauchi; H Maeda
Journal:  Proc Soc Exp Biol Med       Date:  1990-10

Review 2.  Aromatic contributions to circular dichroism spectra of proteins.

Authors:  E H Strickland
Journal:  CRC Crit Rev Biochem       Date:  1974-01

3.  Measurement of total bilirubin by use of bilirubin oxidase.

Authors:  B Perry; B T Doumas; G Buffone; M Glick; C N Ou; K Ryder
Journal:  Clin Chem       Date:  1986-02       Impact factor: 8.327

4.  Estimation of globular protein secondary structure from circular dichroism.

Authors:  S W Provencher; J Glöckner
Journal:  Biochemistry       Date:  1981-01-06       Impact factor: 3.162

5.  'Molten-globule state': a compact form of globular proteins with mobile side-chains.

Authors:  M Ohgushi; A Wada
Journal:  FEBS Lett       Date:  1983-11-28       Impact factor: 4.124

6.  Alpha-Lactalbumin: compact state with fluctuating tertiary structure?

Authors:  D A Dolgikh; R I Gilmanshin; E V Brazhnikov; V E Bychkova; G V Semisotnov; O B Ptitsyn
Journal:  FEBS Lett       Date:  1981-12-28       Impact factor: 4.124

7.  Determination of protein secondary structure in solution by vacuum ultraviolet circular dichroism.

Authors:  S Brahms; J Brahms
Journal:  J Mol Biol       Date:  1980-04       Impact factor: 5.469

8.  Investigation of the use of bilirubin oxidase to measure the apparent unbound bilirubin concentration in human plasma.

Authors:  M E Goldfinch; G A Maguire
Journal:  Ann Clin Biochem       Date:  1988-01       Impact factor: 2.057

9.  Enzymatic removal of bilirubin from blood: a potential treatment for neonatal jaundice.

Authors:  A Lavin; C Sung; A M Klibanov; R Langer
Journal:  Science       Date:  1985-11-01       Impact factor: 47.728

10.  Measurement of direct bilirubin by use of bilirubin oxidase.

Authors:  B T Doumas; B Perry; B Jendrzejczak; L Davis
Journal:  Clin Chem       Date:  1987-08       Impact factor: 8.327

View more
  1 in total

1.  Graphene oxide as a protein matrix: influence on protein biophysical properties.

Authors:  Griselle Hernández-Cancel; Dámaris Suazo-Dávila; Axel J Ojeda-Cruzado; Desiree García-Torres; Carlos R Cabrera; Kai Griebenow
Journal:  J Nanobiotechnology       Date:  2015-10-19       Impact factor: 10.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.